Role of necroptosis in kidney health and disease

[1]  Yuan-fan Zhang,et al.  Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis , 2022, Nature Cardiovascular Research.

[2]  M. Pellegrini,et al.  Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies. , 2022, Gastroenterology.

[3]  C. Hunter,et al.  Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regeneration , 2022, Nature Communications.

[4]  U. Kunzendorf,et al.  Progress and Setbacks in Translating a Decade of Ferroptosis Research into Clinical Practice , 2022, Cells.

[5]  Laura F. Dagley,et al.  Human RIPK3 C-lobe phosphorylation is essential for necroptotic signaling , 2022, Cell Death & Disease.

[6]  K. Scearce-Levie,et al.  Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo‐controlled, double‐blind phase I/Ib studies in healthy subjects and patients , 2022, Clinical and translational science.

[7]  Xiaodong Wang,et al.  Osmotic stress activates RIPK3/MLKL-mediated necroptosis by increasing cytosolic pH through a plasma membrane Na+/H+ exchanger , 2022, Science Signaling.

[8]  Haichao Wang,et al.  Z-DNA binding protein 1 promotes heatstroke-induced cell death , 2022, Science.

[9]  J. Ornato,et al.  Necrosulfonamide improves post-resuscitation myocardial dysfunction via inhibiting pyroptosis and necroptosis in a rat model of cardiac arrest. , 2022, European journal of pharmacology.

[10]  M. Bertrand,et al.  The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach , 2022, Biomedicines.

[11]  Felix Schreibing,et al.  Mapping the human kidney using single-cell genomics , 2022, Nature Reviews Nephrology.

[12]  Xiang Li,et al.  Mosaic composition of RIP1–RIP3 signalling hub and its role in regulating cell death , 2022, Nature Cell Biology.

[13]  Yonghong Zhu,et al.  Excessive Activation of Notch Signaling in Macrophages Promote Kidney Inflammation, Fibrosis, and Necroptosis , 2022, Frontiers in Immunology.

[14]  D. Wallach,et al.  Site-specific ubiquitination of MLKL targets it to endosomes and targets Listeria and Yersinia to the lysosomes , 2022, Cell Death & Differentiation.

[15]  D. Green,et al.  The evolution of regulated cell death pathways in animals and their evasion by pathogens , 2022, Physiological reviews.

[16]  Cheree Fitzgibbon,et al.  Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL , 2021, Cell Death & Differentiation.

[17]  Y. Gorelik,et al.  Hyperglycemia on Admission Predicts Acute Kidney Failure and Renal Functional Recovery among Inpatients , 2021, Journal of clinical medicine.

[18]  Louisa M. S. Gerhardt,et al.  Multi-omic approaches to acute kidney injury and repair. , 2021, Current opinion in biomedical engineering.

[19]  J. Sandow,et al.  Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis , 2021, Nature Communications.

[20]  Laura F. Dagley,et al.  Oligomerization‐driven MLKL ubiquitylation antagonizes necroptosis , 2021, The EMBO journal.

[21]  C. Castiglioni,et al.  Species-Specific Inhibition of Necroptosis by HCMV UL36 , 2021, Viruses.

[22]  G. Ghiggeri,et al.  The spatially resolved transcriptional profile of acute T-cell mediated rejection in a kidney allograft. , 2021, Kidney international.

[23]  H. Nakaya,et al.  Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation. , 2021, Blood.

[24]  P. Tak,et al.  A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis , 2021, BMJ open gastroenterology.

[25]  J. Bertin,et al.  Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance , 2021, Nature Communications.

[26]  A. Gerber,et al.  Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era , 2021, The Journal of biological chemistry.

[27]  Hong-Yang Wang,et al.  The multitargeted kinase inhibitor KW-2449 ameliorates cisplatin-induced nephrotoxicity by targeting RIPK1-mediated necroptosis. , 2021, Biochemical pharmacology.

[28]  Cheree Fitzgibbon,et al.  A family harboring an MLKL loss of function variant implicates impaired necroptosis in diabetes , 2021, Cell Death & Disease.

[29]  Jiangqin Zhao,et al.  Toll‐like receptor 3 is an endogenous sensor of cell death and a potential target for induction of long‐term cardiac transplant survival , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  P. Tak,et al.  A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis , 2021, Arthritis Research & Therapy.

[31]  E. Ars,et al.  Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports , 2021, Clinical kidney journal.

[32]  Michael J Taylor,et al.  Spatially Resolved Mass Spectrometry at the Single Cell: Recent Innovations in Proteomics and Metabolomics , 2021, Journal of the American Society for Mass Spectrometry.

[33]  A. Gaikwad,et al.  6,7-Dihydroxycoumarin ameliorates crystal-induced necroptosis during crystalline nephropathies by inhibiting MLKL phosphorylation. , 2021, Life sciences.

[34]  J. Sandow,et al.  The regulation of necroptosis by post-translational modifications , 2021, Cell Death & Differentiation.

[35]  G. McFadden,et al.  A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation. , 2021, Immunity.

[36]  M. Mann,et al.  Phosphoproteome profiling uncovers a key role for CDKs in TNF signaling , 2020, Nature Communications.

[37]  K. Rogers,et al.  A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells , 2020, Cell Death & Differentiation.

[38]  S. Fulda,et al.  USP22 controls necroptosis by regulating receptor‐interacting protein kinase 3 ubiquitination , 2020, EMBO reports.

[39]  A. Kribben,et al.  Primidone blocks RIPK1-driven cell death and inflammation , 2020, Cell Death & Differentiation.

[40]  M. Murphy,et al.  Mitochondrial ROS prime the hyperglycemic shift from apoptosis to necroptosis , 2020, Cell death discovery.

[41]  P. Schulze-Lefert,et al.  Discovery of a Family of Mixed Lineage Kinase Domain-like Proteins in Plants and Their Role in Innate Immune Signaling. , 2020, Cell host & microbe.

[42]  A. Strasser,et al.  Emerging connectivity of programmed cell death pathways and its physiological implications , 2020, Nature Reviews Molecular Cell Biology.

[43]  C. Pollock,et al.  RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy , 2020, Scientific Reports.

[44]  K. Rogers,et al.  MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis , 2020, Nature Communications.

[45]  M. Stegall,et al.  The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody‐mediated rejection , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[46]  J. Bertin,et al.  Response to Inhibition of Receptor‐Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo‐Controlled Study , 2020, Clinical pharmacology and therapeutics.

[47]  M. Bertrand,et al.  Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation , 2020, Nature Communications.

[48]  X. Tao,et al.  RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis , 2020, Cell Death & Differentiation.

[49]  David F. Boyd,et al.  Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis , 2020, Cell.

[50]  Daling Zhu,et al.  A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome , 2020, Journal of Molecular Medicine.

[51]  Junying Yuan,et al.  Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke , 2020, Proceedings of the National Academy of Sciences.

[52]  Hongxiang Chen,et al.  Inhibition of keratinocyte necroptosis mediated by RIPK1/RIPK3/MLKL provides a protective effect against psoriatic inflammation , 2020, Cell Death & Disease.

[53]  M. Mann,et al.  Quantitative and Dynamic Catalogs of Proteins Released during Apoptotic and Necroptotic Cell Death. , 2020, Cell reports.

[54]  Jun Xie,et al.  Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis , 2020, Disease Models & Mechanisms.

[55]  P. Merkel,et al.  ANCA-associated vasculitis , 2020, Nature Reviews Disease Primers.

[56]  H. Anders,et al.  Lupus nephritis , 2009, Nature Reviews Disease Primers.

[57]  Y. Döring,et al.  Neonatal obstructive nephropathy induces necroptosis and necroinflammation , 2019, Scientific Reports.

[58]  K. Do,et al.  Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes , 2019, Leukemia.

[59]  F. Shao,et al.  The gasdermins, a protein family executing cell death and inflammation , 2019, Nature Reviews Immunology.

[60]  J. Kellum,et al.  Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. , 2019, Kidney international.

[61]  G. Manning,et al.  Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3. , 2019, Cell reports.

[62]  Xiaoqiang Ding,et al.  High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway. , 2019, Experimental cell research.

[63]  N. Yang,et al.  Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation. , 2019, Journal of autoimmunity.

[64]  J. Privratsky,et al.  Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis. , 2019, American journal of physiology. Renal physiology.

[65]  Peter J Cowan,et al.  Regulated necrosis in kidney ischemia-reperfusion injury. , 2019, Kidney international.

[66]  J. Christie,et al.  Plasma receptor interacting protein kinase-3 levels are associated with acute respiratory distress syndrome in sepsis and trauma: a cohort study , 2019, Critical Care.

[67]  Eben M. Olson,et al.  Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease. , 2019, Kidney international.

[68]  R. Blasczyk,et al.  HLA class II antibodies induce necrotic cell death in human endothelial cells via a lysosomal membrane permeabilization-mediated pathway , 2019, Cell Death & Disease.

[69]  U. Kunzendorf,et al.  Combined Knockout of RIPK3 and MLKL Reveals Unexpected Outcome in Tissue Injury and Inflammation , 2019, Front. Cell Dev. Biol..

[70]  J. Koyner,et al.  Sepsis associated acute kidney injury , 2019, British Medical Journal.

[71]  L. Guay-Woodford,et al.  Polycystic kidney disease , 2018, Nature Reviews Disease Primers.

[72]  U. Kunzendorf,et al.  The anticonvulsive Phenhydan® suppresses extrinsic cell death , 2018, Cell Death & Differentiation.

[73]  B. Porto,et al.  Respiratory Syncytial Virus induces the classical ROS-dependent NETosis through PAD-4 and necroptosis pathways activation , 2018, Scientific Reports.

[74]  R. Krüger,et al.  Gasdermin D plays a vital role in the generation of neutrophil extracellular traps , 2018, Science Immunology.

[75]  M. Or-Guil,et al.  BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study , 2018, EBioMedicine.

[76]  F. Chan,et al.  Necroptosis in anti-viral inflammation , 2018, Cell Death & Differentiation.

[77]  M. Sorokin,et al.  Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis , 2018, Cell Death & Differentiation.

[78]  Hao Wu,et al.  The Structure of the Necrosome RIPK1-RIPK3 Core, a Human Hetero-Amyloid Signaling Complex , 2018, Cell.

[79]  V. Ten,et al.  Hyperglycemia potentiates a shift from apoptosis to RIP1-dependent necroptosis , 2018, Cell Death Discovery.

[80]  Junying Yuan,et al.  Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression , 2018, Cell Death & Disease.

[81]  Giou-Teng Yiang,et al.  Current Mechanistic Concepts in Ischemia and Reperfusion Injury , 2018, Cellular Physiology and Biochemistry.

[82]  D. Green,et al.  Phenytoin inhibits necroptosis , 2018, Cell Death & Disease.

[83]  H. Hwang,et al.  Polaronic behavior in a weak-coupling superconductor , 2016, Proceedings of the National Academy of Sciences.

[84]  S. Manohar,et al.  Cisplatin nephrotoxicity: a review of the literature , 2018, Journal of Nephrology.

[85]  R. Oberbauer,et al.  Immunological consequences of kidney cell death , 2018, Cell Death & Disease.

[86]  P. Boor,et al.  Particles of different sizes and shapes induce neutrophil necroptosis followed by the release of neutrophil extracellular trap-like chromatin , 2017, Scientific Reports.

[87]  P. A. Harris,et al.  Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers , 2017, Pharmacology research & perspectives.

[88]  J. Becker,et al.  Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis , 2017, Proceedings of the National Academy of Sciences.

[89]  M. Bertrand,et al.  MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death , 2017, Nature Cell Biology.

[90]  H. Duan,et al.  Inhibition of Necroptosis Attenuates Kidney Inflammation and Interstitial Fibrosis Induced By Unilateral Ureteral Obstruction , 2017, American Journal of Nephrology.

[91]  Se-Jin Yoon,et al.  MLKL, the Protein that Mediates Necroptosis, Also Regulates Endosomal Trafficking and Extracellular Vesicle Generation , 2017, Immunity.

[92]  G. Brumatti,et al.  MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death , 2017, Molecular cell.

[93]  B. Stockwell,et al.  Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure , 2017, Cellular and Molecular Life Sciences.

[94]  D. Green,et al.  ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences , 2017, Cell.

[95]  H. Anders,et al.  Crystal nephropathies: mechanisms of crystal-induced kidney injury , 2017, Nature Reviews Nephrology.

[96]  Seamus J. Martin,et al.  An Inflammatory Perspective on Necroptosis. , 2017, Molecular cell.

[97]  Laura F. Dagley,et al.  EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation , 2017, Nature Microbiology.

[98]  Wei Gan,et al.  Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis , 2016, Science Advances.

[99]  N. van Bruggen,et al.  RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury , 2016, Cell Death and Differentiation.

[100]  D. Fennell,et al.  Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer. , 2016, Cancer treatment reviews.

[101]  Rostyslav Bilyy,et al.  Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis , 2016, Nature Communications.

[102]  C. Mendez,et al.  Hyperglycemia and Acute Kidney Injury During the Perioperative Period , 2016, Current Diabetes Reports.

[103]  H. Anders,et al.  PMA and crystal‐induced neutrophil extracellular trap formation involves RIPK1‐RIPK3‐MLKL signaling , 2016, European journal of immunology.

[104]  S. Kim,et al.  Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation. , 2015, Kidney international.

[105]  J. Bertin,et al.  Absence of RIPK3 predicts necroptosis resistance in malignant melanoma , 2015, Cell Death and Disease.

[106]  B. Kasiske,et al.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2015, Kidney international.

[107]  P. Heuschmann,et al.  Chronic hyperglycemia is associated with acute kidney injury in patients undergoing CABG surgery – a cohort study , 2015, BMC Cardiovascular Disorders.

[108]  M. Perazella,et al.  New drug toxicities in the onco-nephrology world. , 2015, Kidney international.

[109]  F. Chan,et al.  Programmed necrosis in the cross talk of cell death and inflammation. , 2015, Annual review of immunology.

[110]  W. Kaiser,et al.  Manipulation of apoptosis and necroptosis signaling by herpesviruses , 2015, Medical Microbiology and Immunology.

[111]  S. Cullen,et al.  Necroptosis suppresses inflammation via termination of TNF- or LPS-induced cytokine and chemokine production , 2015, Cell Death and Differentiation.

[112]  P. Vandenabeele,et al.  Necroptosis and its role in inflammation , 2015, Nature.

[113]  D. Green,et al.  The two faces of receptor interacting protein kinase-1. , 2014, Molecules and Cells.

[114]  A. Walch,et al.  Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice , 2014, Nature Cell Biology.

[115]  D. Green,et al.  Synchronized renal tubular cell death involves ferroptosis , 2014, Proceedings of the National Academy of Sciences.

[116]  B. Stockwell,et al.  Regulated cell death and inflammation: an auto-amplification loop causes organ failure , 2014, Nature Reviews Immunology.

[117]  Xiao-ming Meng,et al.  Inflammatory processes in renal fibrosis , 2014, Nature Reviews Nephrology.

[118]  J. Dou,et al.  Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus , 2014, Cell Death and Disease.

[119]  A. Lau,et al.  RIPK3‐Mediated Necroptosis Regulates Cardiac Allograft Rejection , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[120]  Weng-Lang Yang,et al.  Receptor-interacting protein kinase 3 deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis , 2014, Critical Care.

[121]  A. Lau,et al.  RIPK3‐Mediated Necroptosis Promotes Donor Kidney Inflammatory Injury and Reduces Allograft Survival , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[122]  Toru Okamoto,et al.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. , 2013, Immunity.

[123]  D. Green,et al.  Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury , 2013, Proceedings of the National Academy of Sciences.

[124]  P. Vandenabeele,et al.  Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models , 2012, Cell Death and Differentiation.

[125]  F. Bemelman,et al.  Viral double-stranded RNA sensors induce antiviral, pro-inflammatory, and pro-apoptotic responses in human renal tubular epithelial cells. , 2012, Kidney international.

[126]  A. Khwaja.  KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[127]  U. Kunzendorf,et al.  Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. , 2012, Kidney international.

[128]  Ji Luo,et al.  Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis , 2012, Proceedings of the National Academy of Sciences.

[129]  Xiaodong Wang,et al.  Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.

[130]  T. Vanden Berghe,et al.  RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. , 2011, Immunity.

[131]  Susan L Furth,et al.  Urological disorders in chronic kidney disease in children cohort: clinical characteristics and estimation of glomerular filtration rate. , 2011, The Journal of urology.

[132]  A. Bello,et al.  Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[133]  C. Libert,et al.  Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? , 2011, Trends in microbiology.

[134]  Na Zhang,et al.  RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis , 2009, Science.

[135]  F. Chan,et al.  Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation , 2009, Cell.

[136]  Tao Wang,et al.  Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.

[137]  Z. Werb,et al.  Netting neutrophils in autoimmune small-vessel vasculitis , 2009, Nature Medicine.

[138]  B. Magenheimer,et al.  A tumor necrosis factor-α–mediated pathway promoting autosomal dominant polycystic kidney disease , 2008, Nature Medicine.

[139]  Alexei Degterev,et al.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury , 2005, Nature chemical biology.

[140]  G. Haegeman,et al.  The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. , 2003, Endocrine reviews.

[141]  Brian Seed,et al.  Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule , 2000, Nature Immunology.